Immunocytokines (ICs) are a class of molecules created by linking tumor-reactive monoclonal antibodies to cytokines that are able to activate immune cells.
This report contains market size and forecasts of Immunocytokines in global, including the following market information:
Global Immunocytokines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Immunocytokines Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Immunocytokines companies in 2021 (%)
The global Immunocytokines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Liver Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Immunocytokines include Alkermes Plc, AstraZeneca Plc, CytImmune, Cytune Pharma, Altor Biosciences Corporation, Apeiron Biologics AG, Paladin Labs, Teva Pharmaceutical Industries Ltd. and Valor Biotherapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Immunocytokines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immunocytokines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Immunocytokines Market Segment Percentages, by Type, 2021 (%)
Liver
Hypothalamus
Fat muscle
B and T lymphocytes
Bone Marrow Endothelium
Global Immunocytokines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Immunocytokines Market Segment Percentages, by Application, 2021 (%)
Tumors and Cancer
Rheumatoid Arthritis
Global Immunocytokines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Immunocytokines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immunocytokines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Immunocytokines revenues share in global market, 2021 (%)
Key companies Immunocytokines sales in global market, 2017-2022 (Estimated), (MT)
Key companies Immunocytokines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alkermes Plc
AstraZeneca Plc
CytImmune
Cytune Pharma
Altor Biosciences Corporation
Apeiron Biologics AG
Paladin Labs
Teva Pharmaceutical Industries Ltd.
Valor Biotherapeutics
Targa Therapeutics Corporation
Immunomedics, Inc.
ImmunGene, Inc.
MolMed S.p.A.
Merck KGaA
Nektar Therapeutics
Pfizer, Inc.
F. Hoffmann-La Roche, Ltd.